4th Quarter - Report

BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.

Period 4th Quarter 2025 Filed Jan 20, 2026 Signed by Jason D. Kaune, Attorney & Agent for Filer

Official filing
Firm
BIOMARIN PHARMACEUTICAL INC.
Client
BIOMARIN PHARMACEUTICAL INC.
Income
—
Expenses
$390,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R.5371: CONTINUING APPROPRIATIONS, ARGICULTURE, LEGISLATIVE BRANCH, MILITARY CONSTRUCTION AND VETERANS AFFAIRS, AND EXTENSIONS ACT, 2026; PROVISIONS RELATED TO JOINT EXPLANTATORY STATEMENT, DIV. B

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 5371 (119th)

Health Issues HCR

H.R.1262: GIVE KIDS A CHANCE ACT OF 2025; PROVISIONS RELATED TO RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM REAUTHORIZATION S.932: GIVE KIDS A CHANCE ACT OF 2025; PROVISIONS RELATED TO RARE PEDIATRIC DISEASE PRIORITY REVIEW VOUCHER PROGRAM REAUTHORIZATION GENERAL DISCUSSIONS REGARDING GENETIC SREENING AND NEWBORN SREENING GENERAL DISCUSSIONS REGARDING ORPHAN DRUGS GENERAL DISCUSSIONS RELATED TO MOST-FAVORED-NATION (MFN) DRUG PRICING GENERAL DISCUSSIONS RELATED TO THE PRIORITY REVIEW VOUCHER PROGRAM

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —
KATHRYN LOWELL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1262 (119th), S. 932 (119th)

Medicare/Medicaid MMM

H.R.1509: ACCELERATING KIDS' ACCESS TO CARE ACT OF 2025; ALL PROVISIONS S.752: ACCELERATING KIDS' ACCESS TO CARE ACT; ALL PROVISIONS S.1637: MVP ACT; ALL PROVISIONS GENERAL DISCUSSIONS REGARDING MEDICAID DRUG REBATE PROGRAM GENERAL DISCUSSIONS REGARDING PRESCRIPTION DRUG REFERENCE PRICING

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1637 (119th), S. 752 (119th), H.R. 1509 (119th)

Tariff (miscellaneous tariff bills) TAR

GENERAL DISCUSSIONS REGARDING TARIFFS ON PHARMACEUTICALS

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC)

Taxation/Internal Revenue Code TAX

GENERAL DISCUSSIONS REGARDING ORPHAN DRUG TAX CREDIT

LobbyistCovered position, as disclosed
JOHN EDWARD GREISSING —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.